Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics. They are advancing a product pipeline for indications with high unmet medical need, including epilepsy, depression, and pain. Their Phase 3 azetukalner program is a key focus, with positive data from the X-TOLE2 study and an anticipated New Drug Application submission in Q3 2026. The company also has ongoing Phase 3 trials for azetukalner in major depressive disorder and bipolar depression, and early-stage pipeline candidates in Phase 1 studies for pain targets. Xenon leverages its expertise in human genetics, ion channel biology, and novel chemistries to develop potent, selective ion channel targeting therapeutics. They are building a fully integrated neuroscience company with strong discovery, clinical development, corporate, and commercial operations.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level